最新报道:According to 21CBR, Huajian Medical announced the completion of the Nanjing ETHK Building on September 22nd, positioning itself as the world's first dedicated R&D base for digital real-world assets (RWAs). Since July, Huajian Medical has acquired a controlling stake in Guofu Quantum and established an innovative drug intellectual property tokenization fund, increasing its market capitalization from HK$3 billion to HK$17 billion. The company has been renamed "Huajian Digital Industry Group" and is collaborating with Renhe Pharmaceutical to establish an OTC pharmaceutical RWA exchange in the United States to promote the digitization and on-chain circulation of medical assets.